Contact a Female Social Worker Today
Since their introduction in 1962, silicone breast implants have been surgically emplaced in an estimated two million American women. Some women get them as part of breast reconstruction therapy following mastectomy for breast cancer, but the majority get them because they want larger breasts
There are a number of Manufacturers who produce Breast Implants and are a part of the Silicone Breast Implant Lawsuits.
Dow Corning was one of the leaders in the production of Silicone Breast Implants.
Dow Corning Corporation was incorporated in 1943 as a joint venture of Corning Class (now Corning Incorporated) and Dow Chemical to develop, produce and market silicones. Corning, Inc. provided the silicone technology and Dow Chemical provided the manufacturing processes. Silicone is a man-made product that is formed from quartz rock, a form of silica.
In 1991, Dow Corning manufactured an sold more that 4,500 silicone-based products to 45,000 customers worldwide, and was considered a leader in the industry. About 1% of total sales in 1991 came from silicone breast implant product.
Other Manufacturers of Silicone Breast Implants include:
- Dow Corning,
- Heyer Schulte,
- American Hospital Supply,
- Natural Y,
- Brystol Meyer Squibb,
- Medical Engineering,
- McGhan Medical,
- Dow Corning,
Baxter Health Care,
In the U.S the implants sold by Allergan Inc. and Johnson & Johnson's unit Mentor were huge. Allergan’s implant business totaled about $300 million in sales for 2010.
The current claims offices offering settlements include: Dow Corning Corporation, Baxter Health Care, Bristol Meyer Squibb, 3M Corporation, McGhan, Mentor, CUI, and Bioplasty.
If you are ill and have been previously implanted with a silicone breast implant by one of the manufacturers listed above you may be entitled to receive a settlement from the claims offices. Contact the Breast Implant Helpline and speak to a Medical social worker and a female breast implant lawyer.
Some of the brand names of eligible breast implants in the RSP are: Heyer-Schulte, American Hospital Supply, Natural Y, Surgitek, Replicon, Natural Y, MEC or Medical Engineering, all polyurethane-covered breast implants, McGhan Medical, and 3M/McGhan.
In November of 1991
The FDA brought together its General and Plastic Surgery Devices Panel to review all of the safety data from the manufacturers' PMA's. The purpose of the panel was to advise FDA as to what they could tell the public about the safety and effectiveness of the silicone breast implants based on the PMA's. The panel was composed of a broad range of experts, including representatives from the fields of plastic surgery, oncology, epidemiology, internal medicine, immunology, radiology, pathology, gynecology, toxicology, sociology, biomaterials and psychology, as well as industry and consumer groups. The panel hearing rejected the data from Dow Corning, Mentor, McGhan, and Bioplasty, concluding there is not sufficient data about the risks and benefits of the devices. The panel recommended the devices stay on the market temporarily and with limited access. The need for more safety data was stressed.